Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The absence of serious adverse events, treatment-related withdrawals, IGF-1 elevation, glucose metabolism impairment, or immunogenic responses represents a favorable safety foundation
References Clinical Review Report: Tesamorelin (Egrifta) [Internet]
Given the emergence of COVID-19 in the second year of the study, trial visits were permitted to be conducted via telephone, during which counseling was provided and safety-related information was collected
Current batch by strength Single vial Batch 001 10-vial kit Batch 001 Use this map to match the strength and vial batch code to the testing record shown on this page
US$ 20.88
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 29.34
US$ 29.49
US$ 27.68
US$ 28.36
US$ 29.76
US$ 29.08
